Current Programs

MPCCC’s mission is to improve cancer outcomes for all through equitable access to precision oncology, clinical trials and high quality, coordinated cancer care.

All Programs
Research and Clinical Trials

Research and Clinical Trials

We are committed to advancing cancer research and translating discoveries into innovation and better outcomes for patients across Victoria.

Research Translation

We support cancer research and translation by:

  • Funding innovative research projects, PhD scholarships, and early and mid-career research awards
  • Strengthening partnerships between clinical, academic and research institutions to support collaboration and innovation
  • Providing resources, infrastructure and other support to enable high-quality cancer research

Cancer Research Resource Grant

In 2024, MPCCC awarded $300,000 across five innovative projects to develop critical resources that can strengthen discovery, translational, and clinical cancer research. The funded projects are helping build research capability and resources that can be accessed and used by researchers across the cancer research community. Read more about the projects supported here

We are also hosting seminars to showcase the funded projects and highlight how researchers can access and use these resources in their own work. Researchers at all career stages are encouraged to attend. Explore upcoming seminars on our Events page.

Precision Treatment Accelerator Grant

Precision oncology remains a key priority for MPCCC. In 2023, we awarded the Precision Treatment Accelerator Grant to support research aimed at advancing precision cancer treatment. A total of $426,184 was awarded across four innovative projects. Read more about the projects supported here.

Clinical Trials

Clinical trials play an important role in improving cancer care by driving innovation and providing access to new and emerging treatments. For people with advanced or poor-prognosis cancer, clinical trials can provide access to treatment options that may otherwise not be available.

Through our Molecular Tumour Boards and MPCCC Fellowship Program, we help connect patients with suitable clinical trial opportunities, and improve equitable access to the latest research and innovation across metro and regional Victoria.

Victorian Rare Cancer Clinical Trials Alliance (VRCCTA)

In September 2025, MPCCC committed ongoing funding to the Victorian Rare Cancer Clinical Trials Alliance (VRCCTA), reinforcing our commitment to improving equitable access to clinical trials for people living with rare and less common cancers. VRCCTA brings together health services, clinicians, researchers, industry sponsors and consumers to increase trial availability, strengthen collaboration and expand access to clinical trials across Victoria.

Through initiatives that support trial matching, early identification of suitable trial opportunities and cross-site referrals across the network, VRCCTA helps connect more individuals to potentially relevant clinical trials, regardless of where they live or receive care.

‍

‍